Sharon Hanegraaf
Vice President of Regulatory Affairs / Argenica Therapeutics
| Rank | Company | # | |
|---|---|---|---|
| 110th | - | Argenica Therapeutics | $3.21m |
| 120th | - | icetana AI | $1.90m |
| 121st | - | CAQ Holdings | $1.89m |
| 122nd | - | EVE Health Group | $1.74m |
| 123rd | - | InteliCare | $1.58m |
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 1622nd | Magnetite Mines | -73.64% | -59.48% |
| 1623rd | Jatcorp | -73.95% | -27.45% |
| 1624th | Argenica Therapeutics | -74.07% | 0% |
| 1625th | Kuniko | -75.09% | 0% |
| 1626th | Universal Biosensors | -75.96% | -54.03% |
|
NEWS: Tagged in Board moves August 7, 2025 | 07 Aug 2025 |
|
NEW ROLE: Vice President of Regulatory Affairs, Argenica Therapeutics | 07 Aug 2025 |
Access to our data for Sharon Hanegraaf is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Sharon Hanegraaf is linked to 1 organisation which is included in 1 list - Public Companies - Industrial WA.
To see the data you will need to Subscribe.